Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Unfolded Protein Response (UPR) is a cellular stress response pathway activated by the accumulation of misfolded proteins in the endoplasmic reticulum (ER). It aims to restore ER homeostasis by reducing protein translation, enhancing protein folding, and promoting the degradation of misfolded proteins. The UPR is mediated by three main branches: PERK, IRE1α, and ATF6. It plays a crucial role in various diseases, including cancer, neurodegenerative disorders, and diabetes.
Drugs targeting the UPR typically work by modulating the activity of the three main branches of the UPR (PERK, IRE1α, and ATF6) to either alleviate ER stress or induce apoptosis in cancer cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Unfolded Protein Response (UPR) pathway (UPR).